8 terminated. 8 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
| Phase 1 | 2 | Terminated 2 |
Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Macular Pigment and Visual Performance in Glaucoma Patients Lutein, zeaxanthin and mesozeaxanthin, Placebo - Glaucoma | Phase 1 / Phase 2 | Terminated | Felipe Medeiros, MD | 8 | 2019-08-21 | 2023-01-03 |
| Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging 7-Tesla MRI, Optical Coherence Tomography, Heidelberg Retina Tomography - Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Terminated | Medical University of Vienna | 120 | 2015-11-01 | 2019-08-22 |
| The Effectiveness of OlogenĀ® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7) Ologen - Glaucoma | Phase 2 | Terminated | The New York Eye & Ear Infirmary | 30 | 2014-01-15 | 2021-03-17 |
| Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension DWT device dose A, Ellex Tango SLT machine, DWT device dose B - Primary Open-angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 1 / Phase 2 | Terminated | OcuTherix, Inc. | 35 | 2013-11-01 | 2017-04-04 |
| Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C AL-59412C injectable solution, Travoprost injectable solution, AL-59412C Vehicle - Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Terminated | Alcon Research | 4 | 2011-06-01 | 2013-10-25 |
| Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, Brinzolamide ophthalmic suspension, 1%, Brimonidine tartrate ophthalmic solution, 0.2% - Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Terminated | Alcon Research | 195 | 2009-10-01 | 2013-07-04 |
| A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension Anecortave Acetate Sterile Suspension, 6 mg/mL, Anecortave Acetate Sterile Suspension, 3.75 mg/mL, Anecortave Acetate Sterile Suspension, 96 mg/mL - Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Terminated | Alcon Research | 197 | 2008-12-01 | 2012-11-30 |
| Comparison of Latanoprost Vs. Timolol Latanoprost, Timolol - Glaucoma | Phase 2 | Terminated | University of Nebraska | 30 | 2003-12-01 | 2023-12-21 |
Glaucoma, Open-Angle (5) · Ocular Hypertension (5) · Low Tension Glaucoma (1)
Eye Diseases (8) · Ocular Hypertension (3) · Optic Nerve Diseases (1)
Brimonidine Tartrate (1) · Latanoprost (1) · Lutein (1) · Timolol (1) · Tomography, Optical Coherence (1) · Zeaxanthins (1) · anecortave acetate (1) · brinzolamide (1) · collagen-glycosaminoglycan copolymer (1)
Alcon Research (3) · Felipe Medeiros, MD (1) · Medical University of Vienna (1) · OcuTherix, Inc. (1) · The New York Eye & Ear Infirmary (1) · University of Nebraska (1)
United States (4) · Austria (1) · Philippines (1)
Carl B Camras, MD (1) · Edgar U. Leuenberger, MD (1) · Felipe A Medeiros, MD, PhD (1) · Gerhard Garhoefer, MD (1) · Harvey Siy Uy, MD (1) · James Teague, BS, Sr. Clinical Manager (1) · Maria I Yap-Veloso, MD (1) · Noga Harizman, MD (1) · Theresa Landry, PhD (1)